檢索結果 - Val Gebski

Refine Results
  1. 1
    Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study.

    Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study. 由 T P Gavaghan, Val Gebski, D. Baron

    出版 1991
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer

    Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer 由 Sandra Turner, S Gruenewald, Nigel Spry, Val Gebski

    出版 2001
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature

    Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and sy... 由 Jannah Baker, Andreas Obermair, Val Gebski, Monika Janda

    出版 2011
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    The Head Injury Retrieval Trial (HIRT): a single-centre randomised controlled trial of physician prehospital management of severe blunt head injury compared with management by paramedics only

    The Head Injury Retrieval Trial (HIRT): a single-centre randomised controlled trial of physician prehospital management of severe blunt head injury compared with management by para... 由 Alan Garner, K. Mann, Michael R. Fearnside, Elwyn Poynter, Val Gebski

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Survival Effects of Postmastectomy Adjuvant Radiation Therapy Using Biologically Equivalent Doses: A Clinical Perspective

    Survival Effects of Postmastectomy Adjuvant Radiation Therapy Using Biologically Equivalent Doses: A Clinical Perspective 由 Val Gebski, Marivic Lagleva, Anthony Keech, John Simes, Allan O. Langlands

    出版 2006
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Modelling interrupted time series to evaluate prevention and control of infection in healthcare

    Modelling interrupted time series to evaluate prevention and control of infection in healthcare 由 Val Gebski, Katherine Ellingson, Jonathan R. Edwards, John A. Jernigan, David G. Kleinbaum

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Randomised controlled trial of the Lidcombe programme of early stuttering intervention

    Randomised controlled trial of the Lidcombe programme of early stuttering intervention 由 Mark Jones, Mark Onslow, Ann Packman, Shelley Williams, Tika Ormond, Ilsa Schwarz, Val Gebski

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Swallowing performance after radiation therapy for carcinoma of the esophagus

    Swallowing performance after radiation therapy for carcinoma of the esophagus 由 Ian C. O'Rourke, K. W. Tiver, Colin A. Bull, Val Gebski, A.O. Langlands

    出版 1988
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men

    Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men 由 P. Y. Liu, Val Gebski, Leo Turner, Ann J. Conway, Susan M. Wishart, David J. Handelsman

    出版 2002
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study

    Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of... 由 Peter Gibbs, Val Gebski, Mark Van Buskirk, Kenneth G. Thurston, David Cade, Guy A. Van Hazel

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device±Metformin±weight loss in endometrial cancer (feMME) trial

    Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device±Metformin±weight loss in endometrial cance... 由 Anna L. Hawkes, Michael Quinn, Val Gebski, Jane E. Armes, Donal J. Brennan, Monika Janda, Andreas Obermair

    出版 2014
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Markers of systemic inflammation predict survival in patients with advanced renal cell cancer

    Markers of systemic inflammation predict survival in patients with advanced renal cell cancer 由 Peter Fox, Harold Hudson, Chris Brown, Sarah J. Lord, Val Gebski, Paul de Souza, Chee Khoon Lee

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Metastatic cutaneous squamous cell carcinoma of the head and neck

    Metastatic cutaneous squamous cell carcinoma of the head and neck 由 Nicolas Oddone, Gary J. Morgan, Carsten E. Palme, Lakmalie Perera, Jennifer Shannon, Eva Wong, Val Gebski, Michael Veness

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis

    Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis 由 Chee Khoon Lee, Johnathan Man, Sarah J. Lord, Matthew Links, Val Gebski, Tony Mok, James Chih‐Hsin Yang

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  15. 15
    Cut‐point for Ki‐67 proliferation index as a prognostic marker for glioblastoma

    Cut‐point for Ki‐67 proliferation index as a prognostic marker for glioblastoma 由 Eugene Wong, Najmun Nahar, Eric Hau, Winny Varikatt, Val Gebski, Thomas S.C. Ng, Jayasingham Jayamohan, Puma Sundaresan

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals

    Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals 由 Nicholas P. West, Peggy L. Horn, David B. Pyne, Val Gebski, Sampo J. Lahtinen, Peter Fricker, Allan W. Cripps

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Randomised trial of SIR-Spheres® plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer

    Randomised trial of SIR-Spheres® plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer 由 Bruce N. Gray, Guy van Hazel, MD Thomas A. Hope, Mark A. Burton, Paul Moroz, J Anderson, Val Gebski

    出版 2001
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen–Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease

    Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen–Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Re... 由 Kenneth F. Bradstock, Ian Bilmon, John Kwan, Kenneth Micklethwaite, Emily Blyth, Stephanie Deren, Angela Bayley, Val Gebski, David Gottlieb

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer

    Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer 由 M. D. Green, Prudence A. Francis, Val Gebski, V. Harvey, Christos S. Karapetis, Arlene Chan, Ray Snyder, Akiko Fong, R. Basser, John Forbes

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Small Cell Lung Cancer

    Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Sm... 由 Pei N. Ding, Sarah J. Lord, Val Gebski, Matthew Links, Victoria Bray, Richard J. Gralla, James Chih‐Hsin Yang, Chee Khoon Lee

    出版 2016
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:

檢索工具: